Exposure and health surveillance in gulf war veterans exposed to depleted uranium

Depleted Uranium: Properties, Uses, and Health Consequences

Volumn , Issue , 2006, Pages 105-120

  Squibb, Katherine S ^a   McDiarmid, Melissa A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55449121655     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. ATSDR (Agency for Toxic Substances and Disease Registry), Toxicological Profile for Uranium. U.S. Department of Health and Human Services, Washington, D.C., 1999.
2. IOM (Institute of Medicine), Gulf War and Health, Volume 1. Depleted Uranium, Pyridostigmine Bromide, Sarin, Vaccines, Eds., C.E. Fulco, C.T. Liverman, and H.C. Sox, Washington, DC, National Academy Press, 2000.
3. The Royal Society, The Health Hazards of Depleted Uranium Munitions Part I. Policy document 6/01. Royal Society, London, 2001, report available at www.royalsociety.ac.uk.
4. McDiarmid, M.A., Squibb, K., and Engelhardt, S.M., Biologic monitoring for urinary uranium in Gulf War I veterans. Health. Phys. 87: 51-56, 2004.
5. OSAGWI (Office of the Special Assistant for Gulf War Illness), Environmental Exposure Report - Depleted uranium in the Gulf (II), Interim Report, U.S. Department of Defense, Washington, DC, 2000, http://www.deploymentlink.osd.mil/du_library/du_ii/.
6. Guilmette, R.A., Parkhurst, M.A., Miller, G., Hahn, F.F., Roszell, L.E., Daxon, E.G., Little, T.T., Whicker, J.J., Cheng, Y.S, Traub, R.J., Lodde, G.M., Szrom, F., Bihl, D.E., Creek, K.L., and McKee, C.B., Human Health Risk Assessment of Capstone Depleted Uranium Aerosols, Columbus, OH: Battelle Press, 2005, http://www.deploymentlink.osd.mil/du_library/du_capstone/index.pdf
7. Army Environmental Policy Institute (AEPI), Health and Environmental Consequences of Depleted Uranium Use in the U.S. Army. Atlanta, GA: AEPI Technical Report, 1995.
8. Toohey, R.E., Excretion of depleted uranium by Gulf War veteran. Radiat. Prot. Dosimetry 105, 171-174, 2003.
9. McDiarmid, M.A., Hooper, F.J., Keogh, J.P., McPhaul, K., Squibb, K., Kane, R., DiPino, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Hamilton, M., Jacobson-Kram, D., Burrrows, B., and Walsh, M., Health effects of depleted uranium on exposed Gulf War veterans, Environ. Res. 82, 168-180, 2000.
10. Leggett, R.W., The behavior and chemical toxicity of U in the kidney: a reassessment. Health Phys. 57, 365-383, 1989.
11. Fernald Environmental Management Project (FEMP), Technical Basis for Internal Dosimetry at the Fernald Environmental Management Project, Revision 3 dated December 23, 1997, Fernald, OH: FEMP Publication SD 2008, 1997.
12. Thun, M.J., Baker, D.B., Steenland, K., Smith, A.B., Halperin, W., and Berl, T., Renal toxicity in uranium mill workers. Scand. J. Work Environ. Health 11, 83-90, 1985.
13. ICRP (International Commission on Radiological Protection), Report of the Task Groups on Reference Man, Vol. 23, Elmsford, NY: Pergamon Press, 1974.
14. NHANES (National Health and Nutrition Examination Survey), Second National Report on Human Exposure to Environmental Chemicals, NCEH Publication No. 02-0716. Atlanta, GA: Centers for Disease Control and Prevention, 2003.
15. Ejnik, J.W., Todorov, T.I., Mullick, F.G., Squibb, K., McDiarmid, M.A., and Centeno, J.A., Uranium analysis in urine by inductively coupled plasma dynamic reaction cell mass spectrometry, Anal. Bioanal. Chem. 382, 73-79, 2005.
16. ICRP (International Commission on Radiological Protection), Age-Dependent Doses to Members of the Public from Intake of Radionuclides, Part 3. Ingestion Dose Coefficients, Oxford: Pergamon Press, ICRP Publication 69, 1995.
17. Squibb, K.S., Leggett, R.W., and McDiarmid, M.A., Prediction of renal concentrations of depleted uranium and radiation dose in Gulf War veterans with embedded shrapnel, Health. Phys. 89: 267-273, 2005.
18. NCRP (National Council on Radiation Protection and Measurements), Limitation of Exposure to Ionizing Radiation. Bethesda, MD: National Council on Radiation Protection and Measurements, Report Number 116, 1993.
19. Voegtlin, I.C. and Hodge, H.C., Eds., Pharmacology and Toxicology of Uranium Compounds, National Nuclear Energy Series (VI). New York: McGraw-Hill, 1949.
20. Voegtlin, C., and Hodge, H.C., Eds., Pharmacology and Toxicology of Uranium Compounds, New York: McGraw-Hill, 1953.
21. Tannenbaum, A., Ed., Toxicology of Uranium. New York: McGraw-Hill, 1951.
22. Hodge, H.C., Stannard, N., and Hursh, J.B., Eds., Uranium, Plutonium, Transplutonic Elements: Handbook of Experimental Pharmacology, Vol. 36. New York: Springer-Verlag, 1973.
23. Parkhurst, M.A., Daxon, E.G., Lodde, G.M., Szrom, F., Guilmette, R.A., Roszell, L.E., Falo, G.A., and McKee, C.B., Depleted Uranium Aerosol Doses and Risks: Summary of U.S. Assessments. Columbus, OH: Battelle Press, 2005, http://www.deploymentlink.osd.mil/du_library/du_capstone/index.pdf.
24. The Royal Society, The Health Effects of Depleted Uranium Munitions. Summary, Policy Document 6/02. Royal Society, London, 2002, report available at www.royalsociety.ac.uk.
25. Bernard, A.M. and Lauwerys, R.R., Dose response relations between urinary cadmium and tubular proteinuria in adult workers. Am. J. Ind. Med. 31: 116-118, 1977.
26. Jarup, L. and Elinder, C.G., Letter to the editor re: Commentary on Dose-response relations between urinary cadmium and tubular proteinuria in adult workers. Am. J. Ind. Med. 31: 119-120, 1997.
27. Hooper, F.J., Squibb, K.S., Siegel E.L., McPhaul, K., and Keogh, J.P., Elevated urine uranium excretion by soldiers with retained uranium shrapnel. Health Phys. 77: 512-519, 1999.
28. McDiarmid, M.A., Squibb, K., Engelhardt, S., Oliver, M., Gucer, P., Wilson, D., Kane, R, Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., and Jacobson-Kram, D., Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged “friendly fire” cohort. J. Occup. Environ. Med. 43, 991-1000, 2001.
29. McDiarmid, M.A., Engelhardt, S., Oliver, M., Gucer, P., Wilson, D., Kane, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Handwerger, B., Albertini, R.J., Jacobson-Kram, D., Thorne, C.D., and Squibb, K., Health effects of depleted uranium on exposed Gulf War veterans: a ten-year follow-up. J. Toxicol. Environ. Health Part A, 67, 277-296, 2004.
30. McDiarmid, M.A., Engelhardt, S., Oliver, M., Gucer, P., Wilson, P.D., Kane, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Albertini, R.J., Gudi, R., Jacobson-Kram, D., Thorne, C.D., and Squibb, K.S., Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium. Int. Arch. Occup. Environ. Health 79: 11-21, 2006.
31. ICRP (International Commission on Radiological Protection), Report of committee II on permissible dose for internal radiation. Health Phys 3: 1-380, 1960.
32. Kathren, R.L. and Weber, J. Eds., Ultrasensitive Techniques for Measurement of Uranium in Biological Samples and the Nephrotoxicity of Uranium. U.S. Nuclear Regulatory Commission, Proceedings of the Meeting. Nuclear Regulatory Commission staff-originated report NUREG/CP-0093, Washington, DC, 1988.
33. Diamond, G., Biological consequences of exposure to soluble forms of natural uranium. Radiat. Prot. Dosimetry 26: 23-33, 1989.
34. Lin, R.H., Wu, L.J., Lee, C.H., and Lin-Shiau, S.Y., Cytogenetic toxicity of uranyl nitrate in Chinese hamster ovary cells. Mutation Res. 319: 197-203, 1993.
35. Miller, A.C., Fuciarelli, A.F., Jackson, W.E., Ejnik, J., Edmond, C., Strocko, S., Hogan, J, Page, N., and Pellmar, T., Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis 13, 643-648, 1998.
36. Miller, A.C., Blakely, W.F., Livengood, D., Whittaker, T., Xu, J., Ejnik, J.W., Hamilton, M.M., Parlette, E., St. John Gerstenberg, H.M., and Hsu, H., Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride, Environ. Health Perspect. 106, 465-471, 1998.
37. Miller, A.C., Stewart, M., Brooks, K., Shi, L., and Page, N., Depleted uraniumcatalyzed oxidative DNA damage: Absence of significant alpha particle decay. J. Inorganic. Biochem. 91, 246-252, 2002.
38. Miller, A.C., Xu, J., Stewart, M., Brooks, K., Hodge, S., Shi, L., Page, N., and McClain, D., Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints, Radiat. Prot. Dosimetry 99, 275-278, 2002.
39. Miller, A.C., Brooks, K., Stewart, M., Anderson, B., Shi, L., McLain, D., and Page, L., Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation, J Environ Radiol 64, 247-259, 2003.
40. Yazzie, M., Gamble, S.L., Civitello, E.R., and Stearns, D.M., Uranyl acetate causes DNA single strand breaks in vitro in the presence of ascorbate (vitamin C), Chem. Res. Toxicol. 16, 524-530, 2003.
41. Stearns, D., Yazzie, M., Bradley, A.S., Coryell, V.H., Shelley, T., Ashby, A., Asplund, C.S., and Lantz, R.C. Uranyl acetate induces hprt mutations and uranium - DNA adducts in Chinese hamster ovary EM9 cells, Mutagenesis 20: 417-423, 2005.
42. Hueper, W.C., Zuefle, J.H., Link, A.M, and Johnson, M.G., Experimental studies in metal carcinogenesis. II. Experimental uranium cancers in rats, J. Natl Cancer Inst. 13, 291-305, 1952.
43. 2) Dust-II. Postexposure retention and biologic effect in the monkey, dog, and rat, Health. Phys. 25, 239-258, 1973.
44. Cross, F.T., Palmer, R.F., Busch, R.H., Filipy, R.E., and Stuart, B.O., Development of lesions in Syrian Golden hamsters following exposure to radon daughters and uranium ore dust, Health Phys. 41, 135-153, 1981.
45. Mitchell, R.E.J., Jackson, J.S., and Heinmiller, B., Inhaled uranium ore dust and lung cancer risk in rats, Health Phys. 76, 145-155, 1999.
46. Hahn, F.F., Guilmette, R.A., and Hoover, M.D., Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats, Environ. Health Perspect. 110, 51-59, 2002.